Status:
COMPLETED
VerifyNow French Registry
Lead Sponsor:
Association Pour le Développement des Soins Cardiologiques de la ville de Chartres
Collaborating Sponsors:
Medtronic
Boston Scientific Corporation
Conditions:
Stent Thrombosis
Clopidogrel
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the effect of clopidogrel or aspirin reactivity as measured by a point-of-care platelet function assay on thrombotic or bleeding events after percutaneous cor...
Eligibility Criteria
Inclusion
- Coronary angioplasty with stent
Exclusion
- Use of AGP2b3a
- Acute myocardial infarction
- No aspirin and clopidogrel pretreatment
- Use of AVK
- Aspirin or clopidogrel contre-indication
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
1001 Patients enrolled
Trial Details
Trial ID
NCT00753753
Start Date
February 1 2008
End Date
November 1 2009
Last Update
June 25 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
cardiology unit / Les hopitaux de Chartres
Chartres, Eure Et Loir, France, 28000